Search Results for: PERSONALIZED MEDICINE Targeted Personalized Therap
Articles
Saama Partners With The Leukemia & Lymphoma Society & Unveils New Capabilities for Award-Winning Life Science Analytics Cloud February 21, 2019
Saama Technologies, Inc. recently announced a new partnership with The Leukemia & Lymphoma Society (LLS), the world’s largest nonprofit dedicated...Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial February 6, 2018
Fibrocell Science, Inc. recently announced that it obtained allowance from the US FDA to initiate enrollment of pediatric patients in...R&D PARTNERSHIPS - Partnering for Progress: How Collaborations Are Fueling Biomedical Advances November 20, 2017
Neil Lesser and Matt Hefner analyze biopharmaceutical partnerships created throughout the past several decades, and based upon a comprehensive database of partnerships formed between 1980 and 2014, they found that R&D-focused partnerships have grown substantially.
ONCOLOGY DIAGNOSTICS - Advancements Paving the Way for More Tailored Drugs November 20, 2017
Divyaa Ravishankar, MS, says pharmaceutical companies have been subjected to a wide variety of external forces compelling them to get innovative about development of new platforms, liaise with new partners, leverage big data toward precision and predictive diagnosis, and identify new markers.
SPECIAL FEATURE - Platform Technologies - Derisking & Transforming Drug Development September 29, 2017
Contributor Cindy H. Dubin, in this second annual report, speaks with several exciting and innovative companies whose platform technologies are transforming drug development.
SPECIAL FEATURE - Platform Technologies: Not Just for Big Pharma October 3, 2016
Contributor Cindy H. Dubin recently spoke with several companies that are debunking the theory that access to the latest technological platforms to aid efficient drug discovery and development is limited to Big Pharma, which can more easily justify the costs of creating and operating innovative platforms.
INDUSTRY PERSPECTIVES - What Surprised You the Most This Past Year?: Your Colleague’s Perspectives June 30, 2016
The Global Formulation Report in this issue provided some interesting data on what has been happening in a number of key sectors over the past year. We thought it would be intriguing to hear what some of your colleagues said surprised them most.
PhRMA Release: Decade of Breakthroughs In Cancer June 6, 2016
The pace of science is yielding remarkable innovation for cancer patients as we learn more about the underlying factors driving...N-of-One Selected by Admera Health to Provide Clinical Interpretation for the OncoGxOne 64-Gene Oncology Panel April 17, 2016
N-of-One, Inc. recently announced that Admera Health has selected N-of-One to provide clinical interpretation of their 64-gene oncology panel, OncoGxOne....NEXT-GENERATION SEQUENCING - NGS: Uniformity Across the Block February 29, 2016
Andrew Birnie, PhD, explores how innovations in instruments, such as the Eco 48 real-time qPCR system (PCRmax), deliver exceptional uniformity, actively improving the reliability and productivity of the working laboratory.
LOC-BASED DEVICES - Lab on Chip – How Far Are We Along the Road? November 18, 2015
Divyaa Ravishankar, MS, indicates LOC-based devices are an integration of multiple disciplines and the miniaturization of the major laboratory procedures. Recently, these devices are branching into additional aspects of healthcare, such as drug delivery, stem cell, environmental monitoring, and synthetic biology.
AAA Announces Positive Results From Phase III Study October 5, 2015
Advanced Accelerator Applications S.A. recently announced that the pivotal Phase III NETTER-1 study for Lutathera (177Lu-DOTATATE) met its primary endpoint...CELLSEARCH System Recognized as Landmark Innovation in Cancer Research August 4, 2015
Janssen Diagnostics recently announced that a clinical trial involving the company’s CELLSEARCH System has been recognized by the editors of...AAA Signs Distribution Agreement With FUJIFILM RI Pharma July 6, 2015
Advanced Accelerator Applications S.A. (AAA) recently announced it has entered into a distribution agreement for Lutathera in Japan with FUJIFILM...INDUSTRY PERSPECTIVES - The Future of the Pharma & Biotech Industries: Your Colleague’s Perspectives June 30, 2015
The Global Formulation Report in this issue provided some interesting data on what has been happening in a number of key sectors over the past 18 months. We thought it would be intriguing to hear what some of your colleagues believe will have a significant impact on the Pharma and Biotech industries throughout the next 5 to 10 years.
Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation March 24, 2015
Immune Pharmaceuticals Inc. recently announced it has entered into a binding memorandum of understanding with Yissum, the Technology Transfer Company...MARKET BRIEF - Miniaturizing Healthcare - From Microelectronics to Nanobiosensing March 3, 2015
Cecilia Van Cauwenberghe, MS, Technical Insights Senior Research Analyst, Frost & Sullivan, reports that the proliferation of lower cost microfluidics-based genomics tools offering improved capabilities and allowing more access to end-users is expected to drive this technology for pharmaceutical and biomedical research throughout the next 5 years.
BIOAVAILABILITY ENHANCEMENT - Potential for Expanding Chemical Space September 2, 2014
Marshall Crew, PhD, focuses on considering what might be achieved if we borrow best practices and processes that have assisted other industries facing growing complexity, in fact, much of the advances in accelerating our solubilization processes are already borrowed from other industries, in many cases even the technologies.
NantBioScience Announces Strategic Collaboration With Celgene January 21, 2014
NantBioScience recently announced a strategic collaboration with Celgene to advance bold research programs to benefit cancer patients in need of...Pfizer’s Lung Cancer Drug Rejected; Deemed Too Costly August 27, 2013
Pfizer Ltd has expressed concern and disappointment that the final appraisal determination (FAD) from the National Institute of Health and...
